These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27556342)

  • 1. Optimisation of one-step desolvation and scale-up of gelatine nanoparticle production.
    Geh KJ; Hubert M; Winter G
    J Microencapsul; 2016 Nov; 33(7):595-604. PubMed ID: 27556342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase: new insights into gelatin nanoparticle cross-linking.
    Fuchs S; Kutscher M; Hertel T; Winter G; Pietzsch M; Coester C
    J Microencapsul; 2010; 27(8):747-54. PubMed ID: 21034367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and in vitro haemolytic evaluation of cryptolepine hydrochloride-loaded gelatine nanoparticles as a novel approach for the treatment of malaria.
    Kuntworbe N; Al-Kassas R
    AAPS PharmSciTech; 2012 Jun; 13(2):568-81. PubMed ID: 22477022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desolvation process and surface characterisation of protein nanoparticles.
    Weber C; Coester C; Kreuter J; Langer K
    Int J Pharm; 2000 Jan; 194(1):91-102. PubMed ID: 10601688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile.
    Shokry M; Hathout RM; Mansour S
    Int J Pharm; 2018 Jul; 545(1-2):229-239. PubMed ID: 29709617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and optimization of gelatin nanoparticles using the miniemulsion process.
    Ethirajan A; Schoeller K; Musyanovych A; Ziener U; Landfester K
    Biomacromolecules; 2008 Sep; 9(9):2383-9. PubMed ID: 18666795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of gelatin nanoparticles using CDI/NHS as a non-toxic cross-linking system.
    Qazvini NT; Zinatloo S
    J Mater Sci Mater Med; 2011 Jan; 22(1):63-9. PubMed ID: 21052793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanical properties of gelatin nanoparticles in dependency of crosslinking time and storage.
    Weiss AV; Fischer T; Iturri J; Benitez R; Toca-Herrera JL; Schneider M
    Colloids Surf B Biointerfaces; 2019 Mar; 175():713-720. PubMed ID: 30612047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
    Ofokansi K; Winter G; Fricker G; Coester C
    Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells.
    Azarmi S; Huang Y; Chen H; McQuarrie S; Abrams D; Roa W; Finlay WH; Miller GG; Löbenberg R
    J Pharm Pharm Sci; 2006; 9(1):124-32. PubMed ID: 16849014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
    Elzoghby AO
    J Control Release; 2013 Dec; 172(3):1075-91. PubMed ID: 24096021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Lactalbumin nanoparticles prepared by desolvation and cross-linking: structure and stability of the assembled protein.
    Arroyo-Maya IJ; Hernández-Sánchez H; Jiménez-Cruz E; Camarillo-Cadena M; Hernández-Arana A
    Biophys Chem; 2014; 193-194():27-34. PubMed ID: 25105879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Bovine Lactoferrin Nanoparticle Prepared by Desolvation Technique.
    Taguchi K; Chuang VTG; Hashimoto M; Nakayama M; Sakuragi M; Enoki Y; Nishi K; Matsumoto K; Seo H; Otagiri M; Yamasaki K
    Chem Pharm Bull (Tokyo); 2020; 68(8):766-772. PubMed ID: 32741918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation.
    Wacker M; Zensi A; Kufleitner J; Ruff A; Schütz J; Stockburger T; Marstaller T; Vogel V
    Int J Pharm; 2011 Jul; 414(1-2):225-32. PubMed ID: 21571055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis.
    Saraogi GK; Sharma B; Joshi B; Gupta P; Gupta UD; Jain NK; Agrawal GP
    J Drug Target; 2011 Apr; 19(3):219-27. PubMed ID: 20540651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective parameters for formulation of gastro adhesive nanoparticles: screening by design-of-experiments approach.
    Kharia AA; Singhai AK
    J Microencapsul; 2014; 31(4):399-405. PubMed ID: 24697180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New method and characterization of self-assembled gelatin-oleic nanoparticles using a desolvation method via carbodiimide/N-hydroxysuccinimide (EDC/NHS) reaction.
    Park C; Vo CL; Kang T; Oh E; Lee BJ
    Eur J Pharm Biopharm; 2015 Jan; 89():365-73. PubMed ID: 25536111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gelatin nanoparticles for NSAID systemic administration: Quality by design and artificial neural networks implementation.
    Koletti AE; Tsarouchi E; Kapourani A; Kontogiannopoulos KN; Assimopoulou AN; Barmpalexis P
    Int J Pharm; 2020 Mar; 578():119118. PubMed ID: 32032642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of surface charge in the desolvation process of gelatin: implications in nanoparticle synthesis and modulation of drug release.
    Ahsan SM; Rao CM
    Int J Nanomedicine; 2017; 12():795-808. PubMed ID: 28182126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study.
    Gaihre B; Khil MS; Lee DR; Kim HY
    Int J Pharm; 2009 Jan; 365(1-2):180-9. PubMed ID: 18790029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.